The Europe Diagnostic Imaging Equipment Market Report is Segmented by Modality (MRI, CT, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy and C-Arms and Mammography), Portability (Fixed Systems and Mobile and Hand-Held Systems), Application (Cardiology, Oncology, Neurology, Orthopedics, and More), and End-User (Hospitals, Diagnostic Imaging Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

Europe Diagnostic Imaging Market was valued at USD 12.32 Billion in 2024 and is expected to reach USD 16.79 Billion by 2030, growing with a CAGR of 5.25% in the forecast period.

The European Diagnostic Imaging Equipment Industry is valued at XX million in 2025 and is projected to reach XX million by 2033, exhibiting a CAGR of 5.60%. The market growth is attributed to the rising prevalence of chronic diseases, increasing healthcare expenditure, and technological advancements in imaging equipment. MRI (Low and Mid Field MRI Systems) is the largest segment, accounting for XX% of the market in 2025. Key industry players include Siemens Healthineers, GE Healthcare, Philips, and Canon Medical Systems. Europe remains a significant market for diagnostic imaging equipment, with Germany, the United Kingdom, France, Italy, and Spain being the major contributors. The rapid adoption of AI and Machine Learning in medical imaging and the increasing demand for personalized and precision medicine drive market growth. However, factors such as high equipment costs, data privacy concerns, and the availability of alternative diagnostic methods may restrain the market's expansion. Key drivers for this market are: , Increase in Geriatric Population and Rising Prevalence of Chronic Diseases; Technological Advancement in Imaging Modalities; Rising Adoption of Medical Imaging Devices. Potential restraints include: , High Cost of Advanced Diagnostic Imaging Devices; Dearth of Radiologists. Notable trends are: Application in Oncology is Expected to Witness the Fastest Growth over the Forecast Period.

Europe Diagnostic Imaging Market Outlook 2031:

The Europe diagnostic imaging market size was valued at USD 9.18 Billion in 2022 and is projected to reach USD 16.46 Billion by 2031, expanding at a CAGR of 6.7% during the forecast period 2023 - 2031. Growth of the market is attributed to the development of advanced devices, rising healthcare expenditure, increasing government initiatives, and growing cases of injuries & accidents.

Imaging equipment like ultrasound and radiographic machines contains research support programs. Magnetic resonance imaging (MRI), x-rays, and computed tomography (CT) scans are additional equipment’s that are used as human research apparatuses.



The Covid-19 pandemic affected the demand and supply of Europe diagnostic imaging market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Diagnostic Imaging Market Trends, Drivers, Restraints, and Opportunities

• Increase in outpatient surgeries is projected to boost the market in the coming years.


• Rise in minimally invasive surgical procedures is major factor fueling the market during forecast period.


• High cost of diagnostic imaging equipment is anticipated to hamper market growth.


• <span style="font-size:12.0pt"&g

The European diagnostic imaging equipment market, valued at approximately €15 billion in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 5.60% from 2025 to 2033. This expansion is driven by several key factors. Firstly, the aging population across Europe is leading to an increased prevalence of chronic diseases requiring frequent diagnostic imaging. Secondly, technological advancements, such as the development of higher-resolution MRI systems and improved image processing techniques, are enhancing diagnostic accuracy and efficiency, fueling market demand. Furthermore, rising healthcare expenditure and increasing government initiatives to improve healthcare infrastructure are contributing to market growth. The adoption of advanced imaging modalities, like low and mid-field MRI systems, is particularly noteworthy, offering a balance between cost-effectiveness and high-quality imaging. This segment is expected to show strong growth within the overall market. However, market growth is not without challenges. High equipment costs and the need for specialized personnel to operate and maintain the technology pose significant restraints. Furthermore, regulatory hurdles and reimbursement policies can impact market penetration. Despite these challenges, the long-term outlook for the European diagnostic imaging equipment market remains positive, driven by continuous technological innovation and the increasing demand for advanced diagnostic capabilities. Segmentation within the market is evolving, with increasing emphasis on portable and mobile imaging solutions designed to improve accessibility and patient care, particularly in underserved areas. The market is expected to see increased consolidation and partnerships among major players as they seek to capitalize on these trends. Key drivers for this market are: , Increase in Geriatric Population and Rising Prevalence of Chronic Diseases; Technological Advancement in Imaging Modalities; Rising Adoption of Medical Imaging Devices. Potential restraints include: , Increase in Geriatric Population and Rising Prevalence of Chronic Diseases; Technological Advancement in Imaging Modalities; Rising Adoption of Medical Imaging Devices. Notable trends are: Application in Oncology is Expected to Witness the Fastest Growth over the Forecast Period.

The Diagnostic Imaging Market Report is Segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), Portability (Fixed Systems, Mobile and Hand-Held Systems), Application (Cardiology, Oncology, Neurology, and More), End User (Hospitals, Diagnostic Imaging Centers, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Concerning the seven selected segments, the segment Siemens Healthineers has the largest value share by brand with ***** percent. Contrastingly, Fujifilm is ranked last, with **** percent. Their difference, compared to Siemens Healthineers, lies at ***** percentage points. Find more statistics on other topics: a comparison of the value share by brand in Asia and a comparison of the value share by brand in the world. The Statista Market Insights cover a broad range of additional markets.

In Europe Medical Imaging Market, Medical imaging technologies are being integrated with genetic testing and other data sources.

Europe medical imaging informatics market will be USD 888.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031. Increasing demand for integrated imaging systems is expected to aid the sales to USD 1332.9 million by 2031

The European diagnostic imaging market, valued at approximately $8.47 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.9% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of chronic diseases like cancer, cardiovascular conditions, and neurological disorders necessitates frequent diagnostic imaging procedures. Technological advancements, such as the development of AI-powered image analysis and minimally invasive imaging techniques, are improving diagnostic accuracy and efficiency, driving market growth. Furthermore, rising geriatric populations across Europe, who generally require more frequent diagnostic imaging, contribute significantly to market demand. Government initiatives aimed at improving healthcare infrastructure and increasing access to advanced imaging technologies are also playing a supportive role. Germany, the UK, and Sweden are key markets within Europe, driving regional growth. However, the market also faces challenges, including high equipment costs, stringent regulatory approvals, and the potential for data privacy concerns related to the increasing use of digital imaging. Competition within the European diagnostic imaging market is intense, with established players like GE Healthcare, Siemens Healthineers, Philips, and Fujifilm competing with emerging companies. These companies employ diverse competitive strategies, including product innovation, strategic partnerships, and mergers and acquisitions, to gain market share. Key segments within the market include X-rays, ultrasound, MRI scans, and CT scans, each exhibiting unique growth trajectories influenced by technological progress and specific clinical applications. The market is further segmented by modality, end-user, and geography, providing opportunities for targeted market penetration. Risks include price pressures from healthcare payers, potential disruptions from emerging technologies, and evolving reimbursement policies. A comprehensive understanding of these market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on growth opportunities.

Snapshot img

Refurbished Medical Imaging Equipment Market Size 2025-2029

The refurbished medical imaging equipment market size is forecast to increase by USD 7.68 billion, at a CAGR of 8.5% between 2024 and 2029.

The market is driven by the increasing demand for cost-effective and efficient medical imaging devices. As healthcare costs continue to rise, the affordability of refurbished equipment becomes an attractive option for healthcare providers. Furthermore, the adoption of eco-friendly practices in the healthcare industry is fueling the market's growth, as refurbished equipment offers a sustainable solution to reducing the environmental impact of medical waste. However, the market faces challenges, including the negative perception of end-users about refurbished medical equipment. Some healthcare providers may view refurbished equipment as less reliable or less advanced than new equipment. Addressing these concerns through certification programs and ensuring the highest quality standards can help alleviate these concerns and expand the market's reach. Companies seeking to capitalize on market opportunities should focus on providing top-notch customer service, offering flexible financing options, and ensuring the highest quality standards for their refurbished medical imaging equipment. By addressing the challenges and leveraging the market's drivers, companies can effectively navigate the competitive landscape and capture a significant share of the market.

What will be the Size of the Refurbished Medical Imaging Equipment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by the ever-changing dynamics of technology and healthcare sector requirements. MRI machines, CT scanners, and X-ray systems are continually upgraded to enhance image quality and enable advanced applications such as precision medicine, image registration, and personalized medicine. Efficiency improvements are a key focus, with equipment financing, quality assurance, and asset management solutions facilitating cost optimization and seamless hospital workflow. CE marking and regulatory compliance ensure the safe and effective use of refurbished imaging equipment. Advancements in medical imaging technology, including 3D imaging, image segmentation, and image analysis, are revolutionizing disease diagnosis and interventional radiology. Big data analytics and artificial intelligence (AI) are increasingly integrated into medical imaging software for early detection and treatment planning. Emerging technologies like image fusion, contrast agents, noise reduction, and machine learning are transforming the industry, offering significant benefits in terms of spatial resolution, contrast resolution, and diagnostic accuracy. Preventive screening and patient monitoring are also gaining importance, with remote diagnostics and real-time image interpretation becoming essential components of the healthcare ecosystem. The ongoing adoption of technology in healthcare is leading to the obsolescence of traditional imaging systems. Maintenance and repair services, along with upgrade options, are crucial for extending the life cycle of refurbished medical imaging equipment. In the realm of cardiovascular imaging, advancements in image acquisition, image processing, and image optimization are enabling more accurate and timely diagnosis. Radiation shielding and image interpretation tools are also essential for ensuring the safety and effectiveness of diagnostic imaging. The integration of medical imaging with healthcare informatics, DICOM standards, and cloud computing is streamlining the management and sharing of medical images, making them more accessible and valuable for clinical trials and research purposes. In conclusion, the market is a dynamic and evolving landscape, characterized by continuous innovation and adaptation to the changing needs of the healthcare sector. From image acquisition and processing to diagnostic accuracy and patient care, refurbished medical imaging equipment plays a crucial role in enhancing the quality and accessibility of healthcare services.

How is this Refurbished Medical Imaging Equipment Industry segmented?

The refurbished medical imaging equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductX-ray imagingUltrasound systemsMRICT scanner imagingSPECT/ PET scannersEnd-userHospitalsDiagnostic centersApplicationCardiovascularOncologyOrthopedicsGynecologyOthersGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaIndiaJapanSouth AmericaBrazilRest of World (ROW).

By Product Insights

The x-ray imaging segment is estim

Europe Medical Image Management Market by Product [PACS (Departmental, Enterprise) Delivery (On-Premise, Cloud-based) VNA (Delivery, Procurement, Vendor) AICA (Vendor), Universal Viewer] End User (Hospitals, Diagnostic Imaging Centres) - Forecast to 2032

In Europe Diagnostic Imaging Market, The synergy of FUJIFILM Healthcare Europe and Fujifilm is central to the Japanese multinational's growth strategy in Europe.

Snapshot img

Medical Imaging Market Size 2025-2029

The medical imaging market size is forecast to increase by USD 15.2 billion at a CAGR of 6% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of chronic conditions leading to an escalating demand for diagnostic imaging. However, the market faces challenges, including the high costs associated with medical imaging equipment and procedures, which may limit accessibility for some patients. MRI machines, CT scanners, X-ray systems, and fluoroscopy systems are some of the most commonly used imaging devices, while image processing software, DICOM standard, and image archiving are essential components of the medical imaging ecosystem.
These factors create a complex landscape for market participants, necessitating strategic planning and operational agility to capitalize on opportunities and navigate challenges effectively. Companies must focus on cost reduction strategies, collaborations, and innovation to remain competitive and meet the evolving needs of healthcare providers and patients. This trend is further fueled by the integration of Artificial Intelligenc (AI) technology into medical imaging, enabling faster and more accurate diagnoses.

What will be the Size of the Medical Imaging Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market encompasses various technologies, including minimally invasive surgery, molecular imaging, confocal microscopy, and image-guided interventions. These innovations have significant social impact by improving diagnostic accuracy and patient outcomes. Cloud computing and data analytics, driven by big data, facilitate efficient workflow and enhance industry standards. Training programs and continuing medical education ensure professionals stay updated with the latest techniques and ethical considerations. Robotic surgery and precision medicine are key trends, while radiation safety and patient safety remain top priorities. Industry professionals employ image guidance systems to ensure quality assurance and adhere to regulatory requirements.

Economic impact is substantial, with healthcare reform driving increased demand for cost-effective solutions. Professional societies and biomedical engineering collaborate to advance technology and address challenges. Molecular imaging and confocal microscopy contribute to early disease detection and personalized treatment plans. Quality assurance and workflow efficiency are essential for delivering optimal patient experiences. Service contracts and ongoing partnerships ensure seamless integration and maintenance of these advanced systems.

How is this Medical Imaging Industry segmented?

The medical imaging industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals
  Diagnostic imaging centers
  Others


Product

  X-ray imaging
  Ultrasound imaging
  MRI
  CT scanner imaging
  SPECT/PET imaging


Application

  Cardiology
  Oncology
  Orthopedics and musculoskeletal
  Neurology
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. The market is witnessing significant growth, with hospitals leading the adoption of advanced imaging technologies. Hospitals serve as the primary hub for comprehensive patient care and diagnostic procedures, utilizing a range of imaging modalities such as MRI, CT, ultrasound, X-ray, and nuclear imaging systems. These technologies enable early disease detection, support clinical decision-making, and facilitate minimally invasive treatments. The emphasis on precision medicine and personalized care has driven the demand for more sophisticated imaging solutions, offering higher resolution, faster processing, and improved diagnostic accuracy. Image analysis, reconstruction, and segmentation are crucial components of the market, with AI-powered solutions gaining popularity for their ability to enhance diagnostic accuracy and streamline clinical workflows.

Telemedicine applications and remote diagnosis have become increasingly important, especially during the ongoing pandemic, allowing healthcare professionals to assess patients from a distance. Medical device manufacturers continue to innovate, developing new imaging technologies such as 3D image rendering, virtual reality applications, and object detection. Radiation therapy, on

The global medical diagnostic imaging market, valued at $10,250 million in 2025, is projected to experience robust growth, driven by a compound annual growth rate (CAGR) of 3.3% from 2025 to 2033. This expansion is fueled by several key factors. Technological advancements, such as the development of AI-powered image analysis tools and portable imaging systems, are improving diagnostic accuracy and accessibility. The rising prevalence of chronic diseases, an aging global population, and increased demand for early disease detection are further boosting market demand. Growth is also propelled by increased healthcare spending, particularly in developing economies, where healthcare infrastructure is undergoing significant expansion. The market is segmented by imaging modality (X-ray, Ultrasound, MRI, Others) and application (Hospital, Clinic, Others), offering diverse opportunities for market players. The competitive landscape is marked by the presence of established multinational corporations like Siemens Healthcare, Philips Healthcare, and GE Healthcare, alongside a growing number of smaller, specialized companies focusing on innovation and niche applications. Regional variations in market growth are expected, with North America and Europe maintaining significant market shares, while emerging economies in Asia-Pacific and the Middle East & Africa are expected to witness substantial growth due to rapid economic development and increasing healthcare investments. The competitive dynamics within the medical diagnostic imaging market are highly intense, characterized by strategic alliances, mergers and acquisitions, and a continuous drive for technological innovation. Companies are focusing on developing advanced imaging solutions with improved image quality, faster processing speeds, and reduced radiation exposure. The integration of digital technologies, such as cloud-based image storage and analysis platforms, is enhancing workflow efficiency and data management capabilities. Furthermore, the growing adoption of telemedicine and remote diagnostics is expanding market access, particularly in underserved regions. Regulatory approvals and reimbursement policies play a significant role in shaping market growth, while cost considerations and the need for skilled professionals remain important challenges to address. Overall, the medical diagnostic imaging market exhibits a promising outlook, with continued expansion expected throughout the forecast period driven by technological advancements, demographic shifts, and increased healthcare spending.

Europe Nuclear Imaging Market size was valued at USD 2.67 Billion in 2024 and is projected to reach USD 4.48 Billion by 2032, growing at a CAGR of 6.7% from 2026 to 2032.

Europe Nuclear Imaging Market Dynamics

The key market dynamics that are shaping the Europe Nuclear Imaging Market include:

Key Market Drivers

Aging Population and Increased Chronic Disease Prevalence: Europe's aging population and increased frequency of chronic diseases are driving up demand for nuclear imaging. According to Eurostat, approximately 30% of Europeans will be over 65 by 2050, increasing the prevalence of age-related disorders such as cardiovascular disease, which accounts for 45% of all fatalities in the region. This demographic transition needs sophisticated diagnostic methods, as nuclear imaging allows for early identification, accurate monitoring, and effective therapy of such illnesses, resulting in better patient outcomes and lower healthcare expenditures.

The global diagnostic and medical imaging market, valued at $10,280 million in 2025, is projected to experience steady growth, driven by a rising aging population, increasing prevalence of chronic diseases necessitating frequent imaging, and technological advancements leading to higher image resolution and faster scan times. The 3.5% CAGR from 2025-2033 indicates a substantial market expansion, primarily fueled by the adoption of advanced imaging modalities like MRI and CT scans in hospitals and ambulatory care settings. Technological innovations such as AI-powered image analysis are enhancing diagnostic accuracy and efficiency, further boosting market growth. While the market faces restraints such as high equipment costs and regulatory hurdles, the overall growth trajectory remains positive. The segmentation reveals a significant share held by X-ray imaging systems due to their wide accessibility and cost-effectiveness, while MRI and CT scanners dominate in terms of revenue generation per unit owing to their sophisticated technology and high diagnostic capabilities. Growth is expected across all regions, with North America and Europe maintaining significant market shares due to well-established healthcare infrastructure and high healthcare expenditure. However, emerging economies in Asia Pacific and the Middle East & Africa are witnessing considerable growth due to increasing healthcare investments and rising awareness about advanced diagnostic techniques. The competitive landscape is characterized by both established multinational players such as Philips Healthcare, Siemens Healthineers, and GE Healthcare (implied from industry knowledge), and smaller, specialized companies focusing on niche areas. These companies are continually investing in R&D to develop innovative imaging technologies and improve their market positions. Strategic collaborations, mergers, and acquisitions are also expected to shape the market dynamics over the forecast period, as companies seek to expand their product portfolios and global reach. The long-term outlook for the diagnostic and medical imaging market remains promising, with continued growth expected as technology progresses and the demand for high-quality healthcare increases globally. This trend indicates a lucrative investment opportunity for stakeholders across the entire value chain.

Eastern Europe Medical Imaging Market comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast potential market management during the forecast period between 2025 - 2033.

The global medical diagnostic imaging market, valued at $10.28 billion in 2025, is projected to experience steady growth, driven by several key factors. Technological advancements, such as the development of AI-powered image analysis tools and improved resolution in MRI and CT scans, are enhancing diagnostic accuracy and efficiency, fueling market expansion. The aging global population, coupled with rising prevalence of chronic diseases like cancer and cardiovascular ailments, necessitates increased diagnostic testing, further bolstering market demand. Growth is also being driven by increasing healthcare expenditure in developing economies and a shift towards minimally invasive procedures, which rely heavily on imaging technologies for guidance. However, high costs associated with advanced imaging equipment and the need for skilled professionals to operate and interpret the results pose challenges to market growth. Furthermore, stringent regulatory approvals for new imaging technologies and reimbursement policies can impact market expansion. Segmentation analysis reveals that hospitals currently dominate the application segment, while X-ray and Ultrasound remain leading modalities due to their relatively lower cost and wider accessibility. The forecast period of 2025-2033 anticipates a compound annual growth rate (CAGR) of 3.5%. This growth will be geographically diverse, with North America and Europe expected to maintain significant market share due to established healthcare infrastructure and high adoption rates of advanced imaging technologies. However, Asia-Pacific is projected to witness substantial growth, driven by rising disposable incomes, improved healthcare access, and increasing investments in healthcare infrastructure across countries like China and India. Competitive dynamics are characterized by the presence of established global players like Siemens Healthcare, Philips Healthcare, and GE Healthcare, alongside emerging companies focused on innovation and cost-effective solutions. The market is expected to witness increased consolidation through mergers and acquisitions as companies strive to expand their product portfolios and geographical reach.

The North America & Europe Companion Animal Diagnostics Imaging Market size was valued at USD 1.94 billion in 2023 and is projected to reach USD 3.24 billion by 2032, exhibiting a CAGR of 7.6 % during the forecasts period. Therefore, the North America & Europe Companion Animal Diagnostics Imaging Market precisely captures diagnostic imaging services for pets. This market comprises of imaging solutions like X-ray, ultrasound, MRI and CT scan which assist in the determination of ailments in pet animals like dogs, cats, and horses among others. Its everyday use includes the identification of bone fractures and tumours, internal organ damage or diseases, and dental conditions. Current issues are the use of better imaging, and application of Artificial intelligence in diagnoses, and there is also a rising population of pet owners exercising their rights to get their pets treated. Remote consultation by the use of telemedicine and mobile veterinary services are also developing and improving the accessibility of diagnostic imaging by pet owners.